A Paradigm Shift Toward Population-Based MRI-Targeted Prostate Cancer Screening
Authors:
- 1 August 2025
- journal article
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 11 (8) , 828
Abstract
This Viewpoint discusses the need to optimize screening strategies for prostate cancer, including more widespread use of magnetic resonance imaging (MRI)–targeted screening, to overcome limitations of prostate-specific antigen testing.Keywords
This publication has 7 references indexed in Scilit:
- MRI in Prostate Cancer Screening: A Review and Recommendations, From the AJR Special Series on ScreeningAmerican Journal of Roentgenology, 2025
- Results after Four Years of Screening for Prostate Cancer with PSA and MRINew England Journal of Medicine, 2024
- Repeated Prostate Cancer Screening Using Prostate-Specific Antigen Testing and Magnetic Resonance ImagingJAMA Network Open, 2024
- Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy OnlyNew England Journal of Medicine, 2022
- MRI-Targeted or Standard Biopsy in Prostate Cancer ScreeningNew England Journal of Medicine, 2021
- A 16-yr Follow-up of the European Randomized study of Screening for Prostate CancerEuropean Urology, 2019
- Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO TrialsAnnals of Internal Medicine, 2017